Performance Period: 2/1/2019 to 7/31/2019
The purpose of the Merck-NJII Biopharmaceutical Training Acceleration Proposal (BTAP) is to provide funding for the development of a training program to enable incumbent employees in the biopharmaceutical industry to acquire competencies in the bioprocess development and manufacturing operations related to the biologics field. The proposal is led by Haro Hartounian, Ph.D. of the New Jersey Innovation Institute. He will serve as both the PI and the Project Manager. Steve Dziennik, Ph.D. and Kelly Woltornist of Merck will serve as co-PIs.
Not yet a member? Learn more about which level of NIIMBL membership is right for you and your organization.
New Jersey Innovation Institute